206 related articles for article (PubMed ID: 31879814)
1. Prospective study on the effect of short-term androgen deprivation therapy on PSMA uptake evaluated with
Ettala O; Malaspina S; Tuokkola T; Luoto P; Löyttyniemi E; Boström PJ; Kemppainen J
Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):665-673. PubMed ID: 31879814
[TBL] [Abstract][Full Text] [Related]
2. Flare on [
Malaspina S; Ettala O; Tolvanen T; Rajander J; Eskola O; Boström PJ; Kemppainen J
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):613-621. PubMed ID: 36161511
[TBL] [Abstract][Full Text] [Related]
3. Impact of uptake time on image quality of [
van der Sar ECA; Viol SLM; Braat AJAT; van Rooij R; Lam MGEH; de Jong HWAM; de Keizer B
Med Phys; 2023 Dec; 50(12):7619-7628. PubMed ID: 37093883
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of [68Ga]Ga-PSMA-11 PET/CT in initial staging of patients with prostate cancer and importance of intraprostatic SUVmax values.
Rogic I; Golubic AT; Zuvic M; Smitran T; Jukic N; Gamulin M; Kastelan Z; Huic D
Nucl Med Rev Cent East Eur; 2024; 27(0):6-12. PubMed ID: 38680016
[TBL] [Abstract][Full Text] [Related]
5. Can the Gleason score be predicted in patients with prostate cancer? A dynamic contrast-enhanced MRI,
Akkaya H; Dilek O; Özdemir S; Taş ZA; Öztürk İS; Gülek B
Diagn Interv Radiol; 2023 Sep; 29(5):647-655. PubMed ID: 37395389
[TBL] [Abstract][Full Text] [Related]
6. Antihormonal-Treatment Status Affects
Kluge K; Haberl D; Einspieler H; Rasul S; Gutschmayer S; Kenner L; Kramer G; Grubmüller B; Shariat S; Haug A; Hacker M
J Nucl Med; 2023 Nov; 64(11):1730-1736. PubMed ID: 37734840
[TBL] [Abstract][Full Text] [Related]
7. Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer?
Demirci E; Kabasakal L; Şahin OE; Akgün E; Gültekin MH; Doğanca T; Tuna MB; Öbek C; Kiliç M; Esen T; Kural AR
Nucl Med Commun; 2019 Jan; 40(1):86-91. PubMed ID: 30395048
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of fully hybrid [
Ghezzo S; Mapelli P; Samanes Gajate AM; Palmisano A; Cucchiara V; Brembilla G; Bezzi C; Suardi N; Scifo P; Briganti A; De Cobelli F; Chiti A; Esposito A; Picchio M
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):907-918. PubMed ID: 37897615
[TBL] [Abstract][Full Text] [Related]
9. Intra-individual comparison of prostate-specific membrane antigen positron emission tomography/computed tomography versus bone scan in detecting skeletal metastasis at prostate cancer diagnosis.
Shanmugasundaram R; Saad J; Heyworth A; Wong V; Pelecanos A; Arianayagam M; Canagasingham B; Ferguson R; Goolam AS; Khadra M; Kam J; Ko R; McCombie S; Varol C; Winter M; Mansberg R; Nguyen D; Bui C; Loh H; Le K; Roberts MJ
BJU Int; 2024 Feb; 133 Suppl 3():25-32. PubMed ID: 37943964
[TBL] [Abstract][Full Text] [Related]
10. Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [
Papp L; Spielvogel CP; Grubmüller B; Grahovac M; Krajnc D; Ecsedi B; Sareshgi RAM; Mohamad D; Hamboeck M; Rausch I; Mitterhauser M; Wadsak W; Haug AR; Kenner L; Mazal P; Susani M; Hartenbach S; Baltzer P; Helbich TH; Kramer G; Shariat SF; Beyer T; Hartenbach M; Hacker M
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1795-1805. PubMed ID: 33341915
[TBL] [Abstract][Full Text] [Related]
11. Contribution of 68 Ga-DOTA-FAPI-04 PET/CT to Prostate Cancer Imaging : Complementary Role in PSMA-Negative Cases.
Ergül N; Çermik TF; Alçın G; Arslan E; Erol Fenercioğlu Ö; Beyhan E; Şahin R; Baloğlu MC; Baykal Koca S; Türkay R; Yücetaş U
Clin Nucl Med; 2024 Mar; 49(3):e105-e110. PubMed ID: 38271254
[TBL] [Abstract][Full Text] [Related]
12. Impact of
Andriole GL; Scarsbrook AF; Savir-Baruch B;
Urol Oncol; 2023 Jun; 41(6):293.e1-293.e7. PubMed ID: 37121865
[TBL] [Abstract][Full Text] [Related]
13. Clinical insignificance of [
Arnfield EG; Thomas PA; Roberts MJ; Pelecanos AM; Ramsay SC; Lin CY; Latter MJ; Garcia PL; Pattison DA
Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4495-4507. PubMed ID: 34136957
[TBL] [Abstract][Full Text] [Related]
14. PET imaging of new target CDK19 in prostate cancer.
Dai D; Yu J; Huang T; Li Y; Wang Z; Yang S; Li S; Li Y; Gou W; Li D; Hou W; Fan S; Li Y; Zhao Y
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3452-3464. PubMed ID: 37278941
[TBL] [Abstract][Full Text] [Related]
15. 68 Ga-PSMA Uptake in the Testis : Two Different Patients With Two Different Diagnosis.
Calderon Tobar MN; Önner H
Clin Nucl Med; 2024 Jun; 49(6):578-579. PubMed ID: 38409760
[TBL] [Abstract][Full Text] [Related]
16. Assessing dynamic metabolic heterogeneity in prostate cancer patients via total-body [
Chen R; Ng YL; Yang X; Zhu Y; Li L; Zhao H; Huang G; Liu J
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):896-906. PubMed ID: 37889299
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of
Shamim SA; Kumar N; Arora G; Jaswal S; Shalimar ; Gamanagatti S; Bal C
Ann Nucl Med; 2024 Feb; 38(2):103-111. PubMed ID: 37926772
[TBL] [Abstract][Full Text] [Related]
18. Strong Correlation Between SUV
Berrens AC; Sorbi MA; Donswijk ML; de Barros HA; Azargoshasb S; van Oosterom MN; Rietbergen DDD; Bekers EM; van der Poel HG; van Leeuwen FWB; van Leeuwen PJ
J Nucl Med; 2024 Apr; 65(4):548-554. PubMed ID: 38485277
[TBL] [Abstract][Full Text] [Related]
19. Atypical Presentation of Liver Metastases of Prostate Cancer in 68Ga-PSMA-11 PET/CT.
Stanzel S; Weitzer F; Janek E; Plhak E; Aigner RM
Clin Nucl Med; 2023 Dec; 48(12):1064-1065. PubMed ID: 37934704
[TBL] [Abstract][Full Text] [Related]
20. Unusual Perineal Metastasis in a Case of Prostate Cancer on 68 Ga-PSMA-11 PET/CT.
Solanki R; Mittal BR; Kumar R; Sekar A; Kumar N
Clin Nucl Med; 2024 Feb; 49(2):e73-e74. PubMed ID: 38049967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
